CrisprQC
Latest round
- Series A
Last raised
- Jan 2024
Total raised
- $12M
Investors
- 3
About CrisprQC
Based in California, US, and founded in 2021, CrisprQC Inc. develops an analytics platform built on CRISPR-Chip. The company was co-founded by Ross Bundy (CEO) and DR. Kiana Aran. In January 2023, CrisprQC Inc. The company offers an analytics platform that is built on CRISPR-Chip that provides data and analytics for CRISPR gene editing. Additionally, the applications include gene cell and gene therapies, diagnostics, plant and animal biology, and academic research.
Who invested in CrisprQC
3 investors across 2 rounds
See all investors in CrisprQC
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CrisprQC
Who invested in CrisprQC?
CrisprQC has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CrisprQC raised?
CrisprQC has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did CrisprQC last raise money?
CrisprQC's most recent round on record is a Series A, in Jan 2024.
What does CrisprQC do?
Based in California, US, and founded in 2021, CrisprQC Inc.
Where is CrisprQC headquartered?
CrisprQC is headquartered in San Diego, US.
Which VCs invest in companies like CrisprQC?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at CrisprQC's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like CrisprQC? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.